Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal
- PMID: 29352409
- DOI: 10.1007/s12223-018-0585-4
Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal
Abstract
Pseudomonas aeruginosa, a Gram-negative, rod-shaped bacterium causes widespread diseases in humans. This bacterium is frequently related to nosocomial infections such as pneumonia, urinary tract infections (UTIs) and bacteriaemia especially in immunocompromised patients. The current review focuses on the recent perspectives on biofilms formation by these bacteria. Biofilms are communities of microorganisms in which cells stick to each other and often adhere to a surface. These adherent cells are usually embedded within a self-produced matrix of extracellular polymeric substance (EPS). Pel, psl and alg operons present in P. aeruginosa are responsible for the biosynthesis of extracellular polysaccharide which plays an important role in cell surface interactions during biofilm formation. Recent studies suggested that cAMP signalling pathway, quorum-sensing pathway, Gac/Rsm pathway and c-di-GMP signalling pathway are the main mechanism that leads to the biofilm formation. Understanding the bacterial virulence depends on a number of cell-associated and extracellular factors and is very essential for the development of potential drug targets. Thus, the review focuses on the major genes involved in the biofilm formation, the state of art update on the biofilm treatment and the dispersal approaches such as targeting adhesion and maturation, targeting virulence factors and other strategies such as small molecule-based inhibitors, phytochemicals, bacteriophage therapy, photodynamic therapy, antimicrobial peptides and natural therapies and vaccines to curtail the biofilm formation by P. aeruginosa.
Keywords: Alginate; Biofilm dispersal; Biofilms; EPS; Gac/Rsm pathway; Pel; Pseudomonas aeruginosa; Psl; Quorum-sensing pathway; Treatment advancement; c-di-GMP signalling pathway.
Similar articles
-
Pseudomonas aeruginosa biofilm: potential therapeutic targets.Biologicals. 2014 Jan;42(1):1-7. doi: 10.1016/j.biologicals.2013.11.001. Epub 2013 Dec 3. Biologicals. 2014. PMID: 24309094 Review.
-
An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal.FEMS Immunol Med Microbiol. 2010 Aug;59(3):253-68. doi: 10.1111/j.1574-695X.2010.00690.x. Epub 2010 Apr 23. FEMS Immunol Med Microbiol. 2010. PMID: 20497222 Review.
-
Distinct roles of extracellular polymeric substances in Pseudomonas aeruginosa biofilm development.Environ Microbiol. 2011 Jul;13(7):1705-17. doi: 10.1111/j.1462-2920.2011.02503.x. Epub 2011 May 23. Environ Microbiol. 2011. PMID: 21605307
-
The role of exopolysaccharides Psl and Pel in resistance of Pseudomonas aeruginosa to the oxidative stressors sodium hypochlorite and hydrogen peroxide.Microbiol Spectr. 2024 Oct 3;12(10):e0092224. doi: 10.1128/spectrum.00922-24. Epub 2024 Aug 28. Microbiol Spectr. 2024. PMID: 39194290 Free PMC article.
-
Molecular Determinants of the Thickened Matrix in a Dual-Species Pseudomonas aeruginosa and Enterococcus faecalis Biofilm.Appl Environ Microbiol. 2017 Oct 17;83(21):e01182-17. doi: 10.1128/AEM.01182-17. Print 2017 Nov 1. Appl Environ Microbiol. 2017. PMID: 28842537 Free PMC article.
Cited by
-
Combination of AS101 and Mefloquine Inhibits Carbapenem-Resistant Pseudomonas aeruginosa in vitro and in vivo.Infect Drug Resist. 2023 Nov 18;16:7271-7288. doi: 10.2147/IDR.S427232. eCollection 2023. Infect Drug Resist. 2023. PMID: 38023412 Free PMC article.
-
Evaluating of the Effects of Sub-MIC Concentrations of Gentamicin on Biofilm Formation in Clinical Isolates of Pseudomonas aeruginosa.Iran J Pathol. 2021 Fall;16(4):403-410. doi: 10.30699/IJP.20201.524220.2584. Epub 2021 Jul 6. Iran J Pathol. 2021. PMID: 34567189 Free PMC article.
-
Effect of Biogenic Silver Nanoparticles on the Quorum-Sensing System of Pseudomonas aeruginosa PAO1 and PA14.Microorganisms. 2022 Aug 30;10(9):1755. doi: 10.3390/microorganisms10091755. Microorganisms. 2022. PMID: 36144357 Free PMC article.
-
Epigallocatechin-3-Gallate Ameliorates Acute Lung Damage by Inhibiting Quorum-Sensing-Related Virulence Factors of Pseudomonas aeruginosa.Front Microbiol. 2022 Apr 25;13:874354. doi: 10.3389/fmicb.2022.874354. eCollection 2022. Front Microbiol. 2022. PMID: 35547130 Free PMC article.
-
Impact of CRAMP-34 on Pseudomonas aeruginosa biofilms and extracellular metabolites.Front Cell Infect Microbiol. 2023 Dec 13;13:1295311. doi: 10.3389/fcimb.2023.1295311. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 38162583 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical